Literature DB >> 2390674

Tetrahydroaminoacridine (tacrine) stimulates neurosecretion at mammalian motor endplates.

S Thesleff1, L C Sellin, S Tågerud.   

Abstract

1. Tacrine (20 microM) induced, like 4-aminoquinoline (4-AQ, 200 microM), the appearance of a population of miniature endplate potentials (m.e.p.ps) with more than twice the normal amplitude or time-to-peak. The times-to-peak of nerve impulse-evoked endplate potentials were not similarly affected. 2. Cholinesterase inhibition by edrophonium (25 microM) did not prevent tacrine or 4-AQ from inducing this population of m.e.p.ps. 3. Nerve-muscle preparations in which the normal calcium-sensitive quantal release of acetylcholine had been blocked by botulinum neurotoxin type A also responded to tacrine by an increase in the frequency of giant or slow m.e.p.ps. 4. Reduction of the temperature from 30 degrees to 14 degrees C reduced the frequency of giant or slow m.e.p.ps induced either by tacrine or by 4-AQ. A similar effect was obtained by colchicine (5 mM). This supports the idea that proximo-distal axonal transport is required for the secretory activity. 5. The neurosecretion evoked by tacrine could explain the therapeutic effects of the drug claimed in the treatment of Alzheimer's type of dementia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2390674      PMCID: PMC1917810          DOI: 10.1111/j.1476-5381.1990.tb15834.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  Presynaptic effect of the neuro-muscular transmitter.

Authors:  J A BARSTAD
Journal:  Experientia       Date:  1962-12-15

2.  On the factors which determine the amplitude of the miniature end-plate potential.

Authors:  B KATZ; S THESLEFF
Journal:  J Physiol       Date:  1957-07-11       Impact factor: 5.182

3.  Trophic functions of the neuron. 3. Mechanisms of neurotrophic interactions. Systems of material transport in nerve fibers (axoplasmic transport) related to nerve function and trophic control.

Authors:  S Ochs
Journal:  Ann N Y Acad Sci       Date:  1974-03-22       Impact factor: 5.691

4.  Discrepancies between spontaneous and evoked synaptic potentials at normal, regenerating and botulinum toxin poisoned mammalian neuromuscular junctions.

Authors:  C Colméus; S Gomez; J Molgó; S Thesleff
Journal:  Proc R Soc Lond B Biol Sci       Date:  1982-04-22

5.  4-aminoquinoline-induced 'giant' miniature endplate potentials at mammalian neuromuscular junctions.

Authors:  J Molgó; S Thesleff
Journal:  Proc R Soc Lond B Biol Sci       Date:  1982-01-22

6.  Giant miniature endplate potentials induced by 4-aminoquinoline.

Authors:  J Molgó; S Gomez; R L Polak; S Thesleff
Journal:  Acta Physiol Scand       Date:  1982-06

7.  Advances in Alzheimer therapy: cholinesterase inhibitors.

Authors:  J W Ashford; K A Sherman; V Kumar
Journal:  Neurobiol Aging       Date:  1989 Jan-Feb       Impact factor: 4.673

8.  Spontaneous release of transmitter from growth cones of embryonic neurones.

Authors:  S H Young; M M Poo
Journal:  Nature       Date:  1983 Oct 13-19       Impact factor: 49.962

9.  Use of THA in treatment of Alzheimer-like dementia: pilot study in twelve patients.

Authors:  W K Summers; J O Viesselman; G M Marsh; K Candelora
Journal:  Biol Psychiatry       Date:  1981-02       Impact factor: 13.382

10.  Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

Authors:  W K Summers; L V Majovski; G M Marsh; K Tachiki; A Kling
Journal:  N Engl J Med       Date:  1986-11-13       Impact factor: 91.245

View more
  7 in total

1.  Effects of tacrine, velnacrine (HP029), suronacrine (HP128), and 3,4-diaminopyridine on skeletal neuromuscular transmission in vitro.

Authors:  M F Braga; A L Harvey; E G Rowan
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

2.  Modulation of Ca(2+)-dependent and Ca(2+)-independent miniature endplate potentials by phorbol ester and adenosine in frog.

Authors:  Timothy J Searl; Eugene M Silinsky
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

3.  Tacrine-induced increase in the release of spontaneous high quantal content events in Torpedo electric organ.

Authors:  C Cantí; E Martí; J Marsal; C Solsona
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

4.  Effectiveness of 1,2,3,4-tetrahydro-9-aminoacridine (THA) as a pretreatment drug for protection of mice from acute diisopropylfluorophosphate (DFP) intoxication.

Authors:  A Galli; F Mori
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

5.  On the possible origin of giant or slow-rising miniature end-plate potentials at the neuromuscular junction.

Authors:  L C Sellin; J Molgó; K Törnquist; B Hansson; S Thesleff
Journal:  Pflugers Arch       Date:  1996-01       Impact factor: 3.657

6.  Butyrylcholinesterase and acetylcholinesterase activity and quantal transmitter release at normal and acetylcholinesterase knockout mouse neuromuscular junctions.

Authors:  Jasmina Minic; Arnaud Chatonnet; Eric Krejci; Jordi Molgó
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

Review 7.  Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease.

Authors:  A J Wagstaff; D McTavish
Journal:  Drugs Aging       Date:  1994-06       Impact factor: 3.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.